Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US
Article
[키워드] 95% CI
Administered
administration
adverse event
age
booster
booster dose
booster vaccination
Booster vaccine
center
collected
Control
Coverage
COVID-19
COVID-19 vaccination
described
evaluate
fatigue
female
headache
Health
help
Impact
IMPROVE
Influenza
influenza vaccine
influenza vaccines
injection
male
Moderna
mRNA
mRNA vaccine
myalgia
Odds ratio
Older
outcome
participant
Pfizer-BioNTech
prevention
receipt
Registered
reported
respiratory infection
respondent
retrospective cohort study
Seasonal influenza
severe complications
Sex
significant increases in
Simultaneous
systemic reaction
vaccination
Vaccine
[DOI] 10.1001/jamanetworkopen.2022.22241 PMC 바로가기 [Article Type] Article
[DOI] 10.1001/jamanetworkopen.2022.22241 PMC 바로가기 [Article Type] Article